Gene: SORL1
Official Full Name: sortilin related receptor 1provided by HGNC
Gene Summary: This gene encodes a mosaic protein that belongs to at least two families: the vacuolar protein sorting 10 (VPS10) domain-containing receptor family, and the low density lipoprotein receptor (LDLR) family. The encoded protein also contains fibronectin type III repeats and an epidermal growth factor repeat. The encoded preproprotein is proteolytically processed to generate the mature receptor, which likely plays roles in endocytosis and sorting. Mutations in this gene may be associated with Alzheimer's disease. [provided by RefSeq, Feb 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04169 | SORL1 Knockout cell line (HeLa) | Human | SORL1 | 1:3~1:6 | Negative | Online Inquiry |
KO04170 | SORL1 Knockout cell line (HCT 116) | Human | SORL1 | 1:2~1:4 | Negative | Online Inquiry |
KO04171 | SORL1 Knockout cell line (HEK293) | Human | SORL1 | 1:3~1:6 | Negative | Online Inquiry |
KO04172 | SORL1 Knockout cell line (A549) | Human | SORL1 | 1:3~1:4 | Negative | Online Inquiry |
SORL1 Gene Knockout Cell Lines are genetically modified cell lines that have undergone targeted gene disruption of the sortilin-related receptor 1 (SORL1) gene. This innovative product serves as a valuable tool for researchers investigating the molecular mechanisms underlying neurodegenerative diseases, particularly Alzheimer's disease. SORL1 plays a critical role in the trafficking and processing of amyloid precursor protein (APP), and its dysfunction has been associated with increased amyloid-beta accumulation, a hallmark of Alzheimer's pathology.
The key function of SORL1 Gene Knockout Cell Lines lies in their ability to provide insights into the consequences of SORL1 deficiency on cellular processes. By studying these knockout cells, researchers can elucidate the resulting alterations in APP processing and subsequent effects on amyloid-beta production. This knowledge is crucial for understanding the pathophysiology of Alzheimer's disease and developing potential therapeutic strategies.
The scientific importance of these cell lines extends beyond basic research; they are valuable models for preclinical studies aimed at testing the efficacy of drug candidates targeting amyloid-beta metabolism. Additionally, they can be utilized in high-throughput screening assays to identify novel compounds that may restore normal SORL1 function or enhance its activity.
Compared to traditional cell lines, SORL1 Gene Knockout Cell Lines offer the unique advantage of creating a more relevant in vitro model that closely mimics pathological conditions associated with diminished SORL1 activity. This specificity enhances the potential for yielding results that are translatable to clinical settings.
For researchers and clinicians dedicated to combating neurodegenerative disorders, these knockout cell lines represent a powerful resource for innovative discoveries that could lead to breakthroughs in Alzheimer’s treatment. With our company’s expertise in providing high-quality biological products and genetic engineering capabilities, we are committed to advancing scientific research and facilitating discoveries that impact human health.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.